We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$202M
AUM Growth
+$26.7M
Cap. Flow
+$20.7M
Cap. Flow %
10.25%
Top 10 Hldgs %
64.02%
Holding
54
New
24
Increased
5
Reduced
9
Closed
15

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$11.5M
2
RXDX
Ignyta, Inc.
RXDX
+$6.33M
3
AVDL
Avadel Pharmaceuticals
AVDL
+$5.74M
4
AET
Aetna Inc
AET
+$4.57M
5
AMGN icon
Amgen
AMGN
+$4.54M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.34M
2
UTHR icon
United Therapeutics
UTHR
+$5.98M
3
PFNX
Pfenex Inc.
PFNX
+$5.15M
4
UNH icon
UnitedHealth
UNH
+$3.13M
5
GTS
Triple-S Management Corporation
GTS
+$2.23M

Sector Composition

Rank Sector Weight
1 Healthcare 55.43%
2 Financials 2.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STML
51
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-140,000
Closed -$2.03M
FWP
52
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
– –
-9,636
Closed -$1.91M
BDSI
53
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-169,200
Closed -$201K
CELG
54
PUT
DELISTED
Celgene Corp
CELG
– –
-525,000
Closed -$60.5M
1 2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Sio Capital Management held 54 positions worth $202M, up 15% from $176M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Sio Capital Management deployed $20.7M of net new capital in Q2 2015, opening 24 new positions and adding to 5 existing holdings. Its largest new stake was GSK: 204,000 shares worth $10.6M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 46% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Pfenex Inc., an estimated $5.15M trimmed.

  • Sio Capital Management's largest Q2 2015 buy was GSK: 204,000 shares worth $10.6M.
  • Sio Capital Management added most to Aratana Therapeutics, Inc. in Q2 2015, an estimated $3.27M increase.
  • Sio Capital Management's biggest Q2 2015 reduction was Pfenex Inc., cutting an estimated $5.15M.
  • Sio Capital Management fully exited Merck in Q2 2015, selling an estimated $8.34M.
  • Sio Capital Management's ten largest holdings make up 64% of its $202M portfolio in Q2 2015.
  • Sio Capital Management opened 24 new positions and closed 15 in Q2 2015.
  • Sio Capital Management's portfolio value rose 15% quarter-over-quarter to $202M.

Based on Sio Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.